Patents by Inventor Julian David Howell

Julian David Howell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10786514
    Abstract: The present invention relates to a dosage regimen of ST10 (ferric maltol) for use in the treatment of patients suffering from iron deficiency with or without anaemia. The invention specifically relates to use of ST10 wherein the dose is between 40 mg and 90 mg twice daily.
    Type: Grant
    Filed: October 21, 2015
    Date of Patent: September 29, 2020
    Assignee: Shield TX (UK) Limited
    Inventors: Nicholas Mallard, Carl Andrew Sterritt, Julian David Howell
  • Patent number: 10179120
    Abstract: The present invention relates to a dosage regimen of ST10 (ferric trimaltol) for the treatment of patients suffering from iron deficiency with or without anaemia. Specifically the invention relates to the treatment of patients with 30 mg ST10 twice daily.
    Type: Grant
    Filed: January 6, 2015
    Date of Patent: January 15, 2019
    Assignee: Iron Therapeutics Holdings AG
    Inventors: Christian Schweiger, Carl Andrew Sterritt, Julian David Howell
  • Publication number: 20170304314
    Abstract: The present invention relates to a dosage regimen of ST10 (ferric maltol) for use in the treatment of patients suffering from iron deficiency with or without anaemia. The invention specifically relates to use of ST10 wherein the dose is between 40 mg and 90 mg twice daily.
    Type: Application
    Filed: October 21, 2015
    Publication date: October 26, 2017
    Inventors: Nicholas Mallard, Carl Andrew Sterritt, Julian David Howell
  • Publication number: 20160324822
    Abstract: The present invention relates to a dosage regimen of ST10 (ferric trimaltol) for the treatment of patients suffering from iron deficiency with or without anaemia. Specifically the invention relates to the treatment of patients with 30 mg ST10 twice daily.
    Type: Application
    Filed: January 6, 2015
    Publication date: November 10, 2016
    Inventors: Christian Schweiger, Carl Andrew Sterritt, Julian David Howell